“Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation”. 2019. Mediterranean Journal of Hematology and Infectious Diseases 11 (1): e2019057. https://doi.org/10.4084/mjhid.2019.057.